Is Ki67 still a powerful ally in predicting the clinical benefit of anthracyclines for the adjuvant treatment of early breast cancer?

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)767-768
Number of pages2
JournalBreast Cancer Research and Treatment
Issue number3
Publication statusPublished - Jan 6 2018

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this